Lucid Group Inc
F:CH2
Lucid Group Inc
F:CH2
Price:
2.64
EUR
Market Cap:
€855.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lucid Group Inc
F:CH2
|
US |
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
Severn Trent PLC
F:SVT
|
UK |
|
Man Wah Holdings Ltd
F:AAM
|
HK |
|
Medistim ASA
OSE:MEDI
|
NO |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
Bollinger Innovations Inc
F:1N5
|
US |
|
D
|
Daiichi Life Group Inc
SWB:QHH
|
JP |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
Westbury Bancorp Inc
OTC:WBBW
|
US |
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
A
|
Agora Inc
XMUN:9AG1
|
US |
|
Red Rock Resorts Inc
NASDAQ:RRR
|
US |
|
P
|
PDF Solutions Inc
XMUN:PD9
|
US |
|
A
|
Autoliv Inc
XMUN:LIV
|
SE |
|
A
|
ADT Inc
SWB:541
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Lucid Group Inc (CH2) under the Base Case is hidden
EUR.
Compared with the current market price of 2.64 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CH2 Multiples-Based Value
LOCKED
